Traditional spinal fusion device markets continue to experience regular growth. This trend is applied across fixation devices, interbody devices, vertebral compression fracture (VCF) treatment, and other product segments. The major competitive limiters are expected to be minimally invasive devices and motion preservation. However, traditional devices currently enjoy a strong advantage over the latter in reimbursement and clinical research.  Continue Reading..

Orthopedic trauma is a long-established market influenced by predictable drivers and limiters. Still, new technologies, increasing unit sales, and average sale prices in decline make this a dynamic market.   Continue Reading..

With the U.S.' investment in R&D and Japan's historically long hospital wait times, each has potential for a telemedicine boom. But China — with its 1.4 billion inhabitants — is poised to exceed the U.S. and Japan in this market, and there are three key reasons this may occur.   Continue Reading..

With some marked regional differences, the Latin American market for dental implant fixtures and final abutments is evolving in response to emerging support technologies and competitive price pressures.  Continue Reading..

Surgical robotics technology has only gained traction in the past decade and faces difficult regulatory paths and cost barriers, among other obstacles, to more widespread use. Still, most robotics companies have expressed interest in global expansion, and having the first-mover advantage is critical to success.  Continue Reading..

Neurovascular medical devices are required to quickly and effectively treat strokes. Technological advancement in these devices, as well as patient demand for minimally invasive procedures is driving growth in the neurovascular device market  Continue Reading..

As women become more comfortable discussing sexual health with medical professionals, the market garners greater attention and receives more funding. Increases in potential patients seeking treatment will correlate with more liberal cultural environments and countries with supportive reimbursement and legislation.  Continue Reading..

The European market for hearing devices has experienced significant growth in recent years. In 2015, the market was valued at just over €7.2 billion. Included in our analysis are the markets for hearing aids, hearing aid batteries, cochlear implants, and bone-anchored hearing aids.  Continue Reading..

Cardiac output (CO) is regarded as a fundamental component of hemodynamic monitoring in critically ill patients. Demand for less-invasive technologies is just one of the factors driving change in the CO monitoring market.   Continue Reading..

Midline catheters are used to obtain short- to intermediate-term peripheral venous access for infusing intravenous fluids and medication. Traditionally, midlines have occupied a niche market between peripherally inserted central catheters (PICCs) and peripheral intravenous catheters (PIVCs).  Continue Reading..

The American market for interventional oncology (IO) devices is a large, diverse, and changing, encompassing many different methodological approaches to the treatment of cancer. As the potential client base increases, avenues for growth will be presented. However, competition between the different modalities will be stiff.  Continue Reading..

Chronic sinusitis affects approximately 12.5 percent of the American population annually. The emergence of balloon sinus dilation has given sufferers an alternative to surgical treatment, and excellent reimbursement rates have boosted the procedure's popularity.  Continue Reading..

The U.S. market for peripheral vascular devices comprises an extensive portfolio of medical devices designed to treat an array of medical conditions. An aging U.S. population and medtech innovation that improves patient outcomes will be among the factors that drive steady growth in the value of the U.S. market for these through 2022.  Continue Reading..

The left atrial appendage, is a small cavity located in the wall of the heart's left atrium, has received significant medical literature coverage in recent years for its role in generating stroke-causing blood clots in patients with non-valvular atrial fibrillation. More recently, the devices designed to close the LAA have become a popular subject for debate among AF patients, regulatory officials, and medical device enthusiasts alike. This...  Continue Reading..

The small bone and joint device market in the Europe consists of reconstructive implants for the extremities, including the shoulder, elbow, hand, and foot. Significant growth in unit sales of key segments is counteracting across-the-board price cuts that are caused by competition and tendering processes in many EU countries. These price declines are causing many niche markets in extremity reconstruction to shrink, despite otherwise stable unit...  Continue Reading..

The market for European orthopedic biomaterials (OB) has undergone dramatic changes over the last two years. Prices, quantities sold, and competitors have been in an almost constant state of flux. While quantities sold are marginally increasing, ASPs (average sales prices) are being driven down by an increase in competition. This analysis includes the markets for bone morphogenetic proteins (BMPs), hyaluronic acid viscosupplementation...  Continue Reading..

Since the launch of LifeCell’s AlloDerm product in the United States in 1994, the use of biologic tissue matrices for soft tissue reinforcement and regeneration has grown considerably.  Continue Reading..

Growth in the spine market today is largely driven by the rapid rise in popularity of some motion preservation devices, most notably artificial discs, and vertebral compression fracture devices. Certain traditional fusion markets are expected to show strong rates of growth, but the overall market will eventually begin to stabilize in value as minimally invasive spine (MIS) procedures become increasingly popular among surgeons. Though the...  Continue Reading..

Accounting for nearly twice the population of the United States and experiencing an increase in over-65 population, Latin America has significant market potential for hearing devices. In Latin America, 4% to 6% of the population is affected by a disabling hearing loss, whereas the rates among North American and European countries are between 2% and 4%, according to World Health Organization estimates. There are approximately 32 million people in...  Continue Reading..

Stem cells derived from embryonic sources have a high degree of therapeutic potential because such immature cells have not yet undergone differentiation: the process of maturation. There are many ethical issues involved with human embryonic stem cell research, despite the regenerative benefits of this form of therapy.  Continue Reading..

Soft tissue is a crucial component of the human body that serves to connect, support, or surround other structures. Seeing as the main component of soft tissue, collagen, is the most abundant protein in mammals, it is of utmost importance that this tissue remains healthy. Complications with soft tissue can result in a myriad of medical conditions that often can only be treated successfully via surgical intervention.  Continue Reading..

The demand to eliminate waste, enhance patient comfort, and ensure quality continues to drive technological advancements in the dental materials market.  Continue Reading..

Population health management (PHM) systems enable payer and provider organizations to analyze the patient populations they represent in order to identify the most high-risk, high-cost patients and implement preventative strategies to improve the morbidity and healthcare usage patterns in these groups. That there is an acute need for these systems is well established. The U.S. spends more on healthcare than similar developed countries. Moreover,...  Continue Reading..

A comprehensive analysis of the European market for laparoscopic devices, with a focus on how market competition and changing reimbursement rates are affecting procedure volumes, sales volumes, and market values of medical devices  Continue Reading..

Two of the latest innovations in the cardiovascular medical device markets are drug-eluting balloon angioplasty and transcatheter heart valve implantation (THVI). The market for drug-coated balloons (DCBs), sometimes referred to as drug-eluting balloons, has emerged as one of the fastest growing markets in the peripheral vascular arena, and clinical trials continue to show positive results associated with the use of DCBs.  Continue Reading..

A political, economic, social, and technological (PEST) analysis of the U.S. urological device market with a focus on the possible impacts that policy changes can have on Medicare and Medicaid Reimbursements, procedure volumes, sales volumes, and market values of medical devices.  Continue Reading..

With the introduction of all-suture anchors and PEEK CF (carbon fiber-reinforced polyetheretherketone) anchors by Biomet and Parcus Medical respectively, there will be a higher level of growth seen in the rotator cuff and shoulder labrum repair markets. This article briefly examines the history of those markets and addresses the major trends that will impact the future of the suture anchor marketplace. By Dr. Kamran Zamanian, CEO, and Dylan...  Continue Reading..

The women’s health device market in the Asia-Pacific region (Japan, South Korea, and Australia) is extremely competitive, with a few manufacturers leading the market. This guest column explores the significant growth areas, particularly the overall assisted reproduction technologies markets, the Japanese breast biopsy markets, and Australia’s breast imaging markets.  Continue Reading..

The need to treat peripheral arterial disease (PAD) has given rise to a multi-billion dollar market for peripheral vascular (PV) medical devices. Three main factors are driving robust growth in the US: the demographic shift, technological innovation, and increases in healthcare expenditures. By Dr. Kamran Zamanian and Rami Faour, iData Research Inc.  Continue Reading..